These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11799430)

  • 41. A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the DiabeDES IV randomized angiography trial).
    Maeng M; Baranauskas A; Christiansen EH; Kaltoft A; Holm NR; Krusell LR; Ravkilde J; Tilsted HH; Thayssen P; Jensen LO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1161-7. PubMed ID: 25640050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction.
    Suryapranata H; van 't Hof AW; Hoorntje JC; de Boer MJ; Zijlstra F
    Circulation; 1998 Jun; 97(25):2502-5. PubMed ID: 9657469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Primary coronary infarct artery stenting in acute myocardial infarction.
    Antoniucci D; Valenti R; Santoro GM; Bolognese L; Trapani M; Moschi G; Fazzini PF
    Am J Cardiol; 1999 Sep; 84(5):505-10. PubMed ID: 10482145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective drug-eluting stent implantation for high-risk patients with acute ST-elevation myocardial infarction: rationale and safety.
    Prasad SB; David T; Malaiapan Y; Cameron JD; Meredith IT
    Catheter Cardiovasc Interv; 2011 Feb; 77(2):193-200. PubMed ID: 20549694
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 1-year clinical outcomes of diabetic patients treated with everolimus-eluting bioresorbable vascular scaffolds: a pooled analysis of the ABSORB and the SPIRIT trials.
    Muramatsu T; Onuma Y; van Geuns RJ; Chevalier B; Patel TM; Seth A; Diletti R; García-García HM; Dorange CC; Veldhof S; Cheong WF; Ozaki Y; Whitbourn R; Bartorelli A; Stone GW; Abizaid A; Serruys PW; ; ; ; ; ;
    JACC Cardiovasc Interv; 2014 May; 7(5):482-93. PubMed ID: 24746650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients.
    Loutfi M; Mulvihill NT; Boccalatte M; Farah B; Fajadet J; Marco J
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):451-4. PubMed ID: 12652493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Mehta RH; Harjai KJ; Cox DA; Stone GW; Brodie BR; Boura J; Grines L; O'Neill W; Grines CL;
    Am J Cardiol; 2005 Oct; 96(7):901-6. PubMed ID: 16188513
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: a subgroup analysis of a randomized controlled trial.
    Harada Y; Colleran R; Kufner S; Giacoppo D; Rheude T; Michel J; Cassese S; Ibrahim T; Laugwitz KL; Kastrati A; Byrne RA;
    Cardiovasc Diabetol; 2016 Sep; 15(1):124. PubMed ID: 27586678
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changing features of stent-supported primary angioplasty for acute myocardial infarction: impact of new flexible stents.
    Tomoda H; Aoki N
    Angiology; 2000 Aug; 51(8):659-66. PubMed ID: 10959518
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contribution of stenting to the results of rescue PTCA.
    Cafri C; Denktas AE; Crystal E; Ilia R; Battler A
    Catheter Cardiovasc Interv; 1999 Aug; 47(4):411-4. PubMed ID: 10470469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sex-based differences in clinical and angiographic outcomes after primary angioplasty or stenting for acute myocardial infarction.
    Antoniucci D; Valenti R; Moschi G; Migliorini A; Trapani M; Santoro GM; Bolognese L; Dovellini EV
    Am J Cardiol; 2001 Feb; 87(3):289-93. PubMed ID: 11165962
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction.
    Nordmann AJ; Bucher H; Hengstler P; Harr T; Young J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005313. PubMed ID: 15846752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coronary stent implantation in diabetic versus nondiabetic patients. Early and late outcomes.
    Bayerl DM; Siqueira E; Moscoso I; Santos E; Maeda A; Bittencourt O; Mauro MF; Cristovão S; Salman A; Sanches G; Mangione JA
    Arq Bras Cardiol; 2000 Nov; 75(5):365-8. PubMed ID: 11080748
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty or fibrinolysis.
    Hsu LF; Mak KH; Lau KW; Sim LL; Chan C; Koh TH; Chuah SC; Kam R; Ding ZP; Teo WS; Lim YL
    Heart; 2002 Sep; 88(3):260-5. PubMed ID: 12181218
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries.
    Hausleiter J; Kastrati A; Mehilli J; Schühlen H; Pache J; Dotzer F; Glatthor C; Siebert S; Dirschinger J; Schömig A;
    J Intern Med; 2004 Nov; 256(5):388-97. PubMed ID: 15485474
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct coronary stent implantation does not reduce the incidence of in-stent restenosis or major adverse cardiac events: six month results of a randomized trial.
    IJsselmuiden AJ; Serruys PW; Scholte A; Kiemeneij F; Slagboom T; vd Wieken LR; Tangelder GJ; Laarman GJ
    Eur Heart J; 2003 Mar; 24(5):421-9. PubMed ID: 12633544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Determinants of long-term follow-up after stent implantation in acute myocardial infarction].
    Heidland UE; Michel CJ; Aktug O; Heintzen MP; Strauer BE
    Z Kardiol; 2002 Nov; 91(11):905-12. PubMed ID: 12442193
    [TBL] [Abstract][Full Text] [Related]  

  • 59. REVascularization with paclitaxEL-coated balloon angioplasty versus drug-eluting stenting in acute myocardial infarcTION-A randomized controlled trial: Rationale and design of the REVELATION trial.
    Vos NS; van der Schaaf RJ; Amoroso G; Herrman JP; Patterson MS; Slagboom T; Vink MA
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1213-21. PubMed ID: 26370515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents.
    Billinger M; Räber L; Hitz S; Stefanini GG; Pilgrim T; Stettler C; Zanchin T; Pulver C; Pfäffli N; Eberli F; Meier B; Kalesan B; Jüni P; Windecker S
    Am Heart J; 2012 May; 163(5):876-886.e2. PubMed ID: 22607867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.